Pamela Ohashi, PhD, FRSC

Director, Tumor Immunotherapy Program

Dr. Ohashi received her PhD from the University of Toronto with Dr. Tak Mak, and did her post-doctoral training at the University of Zurich with the Nobel Laureate Dr. Rolf Zinkernagel, and Dr. Hans Hengartner.  She is the Co-Director of the Campbell Family Institute for Breast Cancer Research, Senior Scientist at the Princess Margaret Cancer Centre, and Professor in the Departments of Medical Biophysics and Immunology at the University of Toronto. She is also the Director of the Tumor Immunotherapy Program at the Princess Margaret Cancer Centre.

Dr. Ohashi’s research interests involve understanding T cell tolerance, strategies to promote tissue specific immune responses and translating these findings in clinical trials.

Dr. Ohashi has received a number of prestigious awards and honors including the American Association of Immunologists (AAI) Pharmingen Investigator Award, the National Cancer Institute of Canada’s William E. Rawls Award, The Canadian Society of Immunology’s Investigator Award as well as a Tier 1 Canada Research Chair. She currently serves as Chair of the Cancer Immunotherapy Steering Committee of the American Association for Cancer Research (AACR), and on the Board of Directors of the Society for Immunotherapy of Cancer (SITC). She has also been elected as a member of the Royal Society of Canada.